Plasmatech Biopharmaceuticals Inc. (PTBI) 6.61

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Plasmatech Biopharmaceuticals Inc. (PTBI) 6.61 $PTBI

Abeona Therapeutics (Nasdaq: ABEO), formerly known as PlasmaTech Biopharmaceuticals, Inc. to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Fri Jun 19, 9:00AM CDT
What:
PTBI: 6.61 (+0.08), NDAQ: 63.00 (-1.41), ABEO: 2.56 (-0.15)

PlasmaTech Biopharmaceuticals Announces Name Change to Abeona Therapeutics to Reflect Broader Rare Disease Commitment
Marketwired - Fri Jun 19, 7:03AM CDT
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, today announced a name change to Abeona Therapeutics, Inc. to reflect its broader rare disease commitment. The Company expects that its common stock will begin trading on NASDAQ on Monday, June 22, under the ticker symbol ABEO, along with announcing Abeona Therapeutics to ring the Nasdaq Stock market closing bell on Monday, June 22nd at 4:00 pm ET. Live streaming can be found at: https://new.livestream.com/nasdaq/live)
PTBI: 6.61 (+0.08)

PlasmaTech Biopharmaceuticals to Present at the 2015 BIO International Convention
Marketwired - Wed Jun 17, 6:03AM CDT
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, announced today that Tim Miller, Ph.D., President & CEO, will be presenting at the 2015 BIO International Convention at the Pennsylvania Convention Center. Management is available throughout the conference for the one-on-one meetings as well.
PTBI: 6.61 (+0.08)

PlasmaTech Biopharmaceuticals Expands Rare Disease Pipeline With License Agreement for Gene Therapy in Fanconi Anemia & CRISPR/Cas9-Based Technology Platform for Rare Blood Disorders
Marketwired - Mon Jun 15, 6:03AM CDT
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI)
PTBI: 6.61 (+0.08)

PlasmaTech Biopharmaceuticals Announces License Agreement for AAV Gene Therapy to Treat Patients With Juvenile Batten Disease
Marketwired - Mon Jun 08, 6:03AM CDT
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI)
PTBI: 6.61 (+0.08)

Male Infertility - Pipeline Review, H1 2015
M2 - Fri Jun 05, 4:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/877pz8/male_infertility) has announced the addition of the "Male Infertility - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Male Infertility, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Male Infertility and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AlphaMab Co., Ltd - Pantarhei Bioscience BV - PharmaEssentia Corporation - PlasmaTech Biopharmaceuticals, Inc. - Zydus Cadila Healthcare Limited Drug Profiles - (oxytocin estrogen) - Biosimilar 4 for Acute Myocardial Infarction and Infertility - Biosimilar 5 for Infertility - Biosimilar 6 for Infertility - Biosimilar 7 for Infertility and Oncology - LM-001 - LM-002 - MCS-5 - Oral Fertility Drugs - PEG-FSH - Small Molecule to Agonize FSHR for Infertility - Small Molecules for Male Infertility - Stem Cell Therapy for Male Infertility For more information visit http://www.researchandmarkets.com/research/87...nfertility
PTBI: 6.61 (+0.08)

PlasmaTech Biopharmaceuticals to Present at the 2015 Jefferies Healthcare Conference
Marketwired - Mon Jun 01, 9:37AM CDT
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, announced today that they will be presenting at the 2015 Jefferies Conference at the Grand Hyatt Hotel. Management is available throughout the conference for the one-on-one meetings as well.
PTBI: 6.61 (+0.08)

PlasmaTech Biopharmaceuticals to Present at the 2015 LD Micro Invitational Conference
Marketwired - Fri May 29, 12:29PM CDT
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, announced today that they will be presenting at the 2015 LD Micro Invitational Conference. Management is available throughout the conference for the one-on-one meetings as well.
PTBI: 6.61 (+0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kailas Campaign Binds Climbers with Gear, Trust

Updated Category News Views 5

Embracing the Spirit of Climbing Connections Alright, so when's the last time you saw a brand digging into the human side of one rugged sport like climbing? That's where Kailas steps in, pulling us beyond gear talk into the trust and camaraderie that defines climbing. Their latest effort—dubbed “Stay Warm, Stay Together”—goes beyond mere technical prowess by...

Continue Reading
RingConn Smart Ring Gains Key FDA 510(k) Clearance

Updated Category News Views 15

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...

Continue Reading
Kexing Biopharm Expands Global Reach at CPHI Milan

Updated Category News Views 14

Kexing Biopharm's Showstopper Moment in Milan Call it a strategic blowout or just audacious timing—Kexing Biopharm's move at the CPHI Milan 2026 has painted a clear picture. From October 6th to 8th, Milan was the stage where Kexing rolled out its showcase, bragging about a pipeline that screams innovation and possibility. And let’s be honest, their timing couldn’t...

Continue Reading
Jiangxi Dialogues: Youths Forge Global Ties in 2026

Updated Category News Views 8

Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...

Continue Reading
New Docs Spotlight Psychiatry on World Mental Health Day

Updated Category News Views 8

Unmasking Mental Health on the Global Stage Hold onto your hats, folks. The Scientology Network is cranking up the heat this World Mental Health Day. On October 10, they’re rolling out a program that puts the spotlight on CCHR’s crusade against what they see as dark forces in the psychiatric industry. It’s a marathon of documentaries that dives into allegations of...

Continue Reading
Zoomlion Boosts Mining Gear Amid Global Revenue Surge

Updated Category News Views 10

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...

Continue Reading
Amap, Sands China Unleash Tutu Robots for Resort Duty

Updated Category News Views 7

Tutu Robots Usher in a New Technological Era for Sands China Alright, let's dive into some tech that feels out of a sci-fi movie and see what Sands China and Amap have cooked up as they introduce the Tutu robot dogs to Sands Resorts Macau. These aren't your run-of-the-mill gadgets—they're futuristic tour guides ready to rewire visitor experiences. The delivery ceremony...

Continue Reading
Young Visionaries Win Junior Medals at STARMUS VIII

Updated Category News Views 11

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

Continue Reading
Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Updated Category News Views 5

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Continue Reading
Arrvel's Thermal Printers: Aiming at E-Com Sellers

Updated Category News Views 12

Arrvel's Thermal Printing Push: An Overview No one would have pegged tiny thermal label printers as game-changers, but here we are. Arrvel's new lineup of thermal printers is shaking up the world for anyone who's ever had to slap on a shipping label or get inventory organized. They're targeting e-commerce folks and small businesses, which sounds like the right move as...

Continue Reading

Top 5 Most Recently Viewed Articles

Kaixin Holdings Shares Details from Annual Shareholder Meeting

Updated Category News Views 153

Kaixin Holdings Shares Outcomes from Annual Meeting BEIJING - Kaixin Holdings, also known as the Company, reported recent developments following its annual general meeting. At this event, all resolutions presented to shareholders were successfully approved, contributing to the Company’s progressive plans. Details of the Annual General Meeting During the gathering,...

Continue Reading
Lantronix Achieves Finalist Status Among Software Industry Leaders

Updated Category News Views 67

Lantronix Inc. hit the scene hard back in 2024 when it snagged a finalist spot in The Top 100 Software Companies ranking. This wasn’t just some random recognition; traders knew this was a signal that the company was making waves in the IoT solutions space. You gotta respect that kind of hustle, right? But what does it really mean for those sitting on LTRX shares? I...

Continue Reading
Eli Lilly's EBGLYSS Shows Promising Long-Term Eczema Results

Updated Category News Views 403

Eli Lilly's EBGLYSS Achieves Remarkable Skin Clearance in Eczema Patients Recent findings reveal that Eli Lilly and Company's (NYSE: LLY) EBGLYSS, a novel treatment for moderate-to-severe atopic dermatitis, has achieved commendable results over a three-year period. Approximately 50% of patients who responded to EBGLYSS treatment at Week 16 reached complete skin clearance,...

Continue Reading
Arcads.ai Secures $16M Seed Funding for Future Growth

Updated Category News Views 289

Arcads.ai Secures $16 Million in Seed Funding Arcads.ai, an innovative platform dedicated to creating high-performing marketing videos with the help of AI technology, has successfully secured 16 million dollars in seed funding. This exciting funding round, led by Eurazeo and supported by Alpha Intelligence Capital along with other global investors, will significantly...

Continue Reading
Middlefield Canadian Income PCC Updates on Net Asset Value Per Share

Updated Category News Views 75

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC is an innovative investment vehicle based in Jersey, specifically structured as a protected cell company. This format allows diverse investment strategies while protecting the assets of different cells from each other, creating a safeguarded approach for all investors involved. The company is...

Continue Reading